Robert Fisher

Publication Details

  • Dextromethorphan for treatment of complex partial seizures.

    Fisher RS, Cysyk BJ, Lesser RP, Pontecorvo MJ, Ferkany JT, Schwerdt PR, Hart J, Gordon B. Neurology. 1990; 40 (3 Pt 1): 547-9

    We performed a double-blind, crossover, add-on study of the antitussive agent dextromethorphan (DM 120 mg/d) as therapy for seizures on 9 patients suffering from severe complex partial seizures. DM had no significant influence on key laboratory values, nor on anticonvulsant drug levels. Side effects were negligible. Complex partial seizure frequency increased 25% during the DM arm of the study, although this increase was not clinically significant.

    PubMedID: 2314601

Stanford Medicine Resources:

Footer Links: